Craft

Ortho Clinical Diagnostics

Revenue

$2 B

FY, 2022

Ortho Clinical Diagnostics Summary

Company Summary

Overview
Ortho Clinical Diagnostics Holdings is a company that provides in vitro diagnostics solutions to clinical laboratories and immunohematology communities. It offers chemistry and immunodiagnostics solutions, including integrated chemistry systems, immunodiagnostic systems, laboratory automation, and middleware solutions, as well as acute kidney injury-acute renal failure testing devices and meters. The company also provides transfusion medicine solutions such as immunohematology analyzers, workstations, and reagents, as well as donor screening solutions. Ortho-Clinical Diagnostics develops predictive technologies and offers inventory management, laboratory optimization, and training and education services.
Type
Subsidiary
Status
Active
Founded
1939
HQ
Raritan, NJ, US | view all locations
Website
https://www.orthoclinicaldiagnostics.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Michael S. Iskra

    Michael S. Iskra, Executive Vice President of Commercial Excellence and Strategy

  • Paul Hackworth

    Paul Hackworth, Managing Director (UK, Benelux and Nordics)

  • Enrique Sobrino

    Enrique Sobrino, Director People and Culture Latin America

  • Rogerio Branconaro

    Rogerio Branconaro, Director Supply Chain Latin America

Operating MetricsView all

Countries (Facilities)

35

Q3, 2020

Countries

130

Q3, 2020

Product Categories (Clinical Laboratories)

7

Q3, 2020

LocationsView all

31 locations detected

  • Raritan, NJ HQ

    United States

    1001 US Route 202

  • Rochester, NY

    United States

    100 Indigo Creek Dr

  • Mulgrave, VIC

    Australia

    Level 2, 8 Nexus Court, Nexus Corporate Park

  • Wien, Wien

    Austria

    Floridsdorfer Hauptstraße 1/ B10

  • Zaventem, Vlaams Gewest

    Belgium

    Da Vincilaan 1

  • São Paulo, São Paulo

    Brazil

    Av. Dr. Chucri Zaidan, 920 – 7º andar, Torre I

and 25 others

Ortho Clinical Diagnostics Financials

Summary Financials

Revenue (Q1, 2022)
$500.1M
Net income (Q1, 2022)
$14.8M
EBIT (Q1, 2022)
$47.1M

Footer menu